Exploring the Experience of Using a Prayer Mobile App

September 17, 2025 updated by: Todd Hall, Biola University

Feasibility and Preliminary Efficacy of Using a Faith and Prayer Mobile App, Pray.Com, on Mental Health and Well-being in a Sample of Racial/Ethnic Minorities

The goal of this clinical trial is to explore the feasibility and preliminary effects of using Pray.com on spiritual well-being and mental health symptoms in racial/ethnic minority adults. The main question it aims to answer is: What are the feasibility and preliminary effects of using Pray.com on spiritual well-being and mental health (stress, depressive and anxiety symptoms) in racial ethnic minority adults (i.e., individuals who identify as Black/African American, Latinx/Hispanic, Asian/Pacific Islander, Native American, or Multiracial)?

Participants will be given the Pray.com app and directed to use it daily. Participants will complete measures at baseline (i.e., time 1) and four-weeks (i.e., time 2). A smaller subset of participants will be asked to participate in a qualitative interview.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Participants (N = 75) will be recruited through social media and various Christian organizations that serve racial/ethnic minorities. Participants will be over the age of 18 and identify as a racial/ethnic minority (i.e., individuals who identify as Black/African American, Latinx/Hispanic, Asian/Pacific Islander, Native American, or Multiracial). Participants also must be willing to participate in a study that involves engaging in a regular Christian religious practice and are willing to download the Pray.com app.

Eligible participants will be given the Pray.com app and directed to use it daily. Participants will complete measures at baseline (i.e., time 1) and four-weeks (i.e., time 2). At the end of the study participants will be randomly asked to participate in an interview (N = 15) which will take no longer than 60 minutes.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
77

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • United States
    • California
      • La Mirada, California, United States, 90637
        • Biola University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 18 years of age or older.
  • Identify as a racial/ethnic minority (e.g., Black/African American, Latinx/Hispanic, Asian/Pacific Islander, Native American, Multiracial).
  • Own a smart phone and be willing to download a mobile app.
  • Willing to engage in a Christian-based religious practice on a mobile app.

Exclusion Criteria:

  • n/a

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Prayer app
Participants will be given the Pray.com app and directed to use it daily.
Behavioral: Prayer app
Participants will be given the Pray.com app and directed to use it daily.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Acceptability of Mobile App
Time Frame: 1 month
9 questions created for the present study, Minimum value: 1, Maximum value: 5, Higher scores reflect higher acceptability (i.e., better outcome)
1 month
Demand for Mobile App
Time Frame: 1 month
3 questions created for the present study, Minimum value: 1, Maximum value: 5, Higher scores reflect higher demand (i.e., better outcome)
1 month
Practicality of Mobile App
Time Frame: 1 month
5 questions created for the present study, Minimum value: 1, Maximum value: 5, Higher scores reflect higher practicality (i.e., better outcome)
1 month
Minutes of App Use
Time Frame: 1 month
How many minutes did the participant use the mobile app?
1 month
Days of App Usage
Time Frame: 1 month
How many days did the participant use the mobile app?
1 month

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Spiritual Well-being Scale
Time Frame: 1 month
Minimum value: 1, Maximum value: 6, Higher scores reflect higher spiritual well-being (i.e., better outcome)
1 month
Satisfaction With Life Scale
Time Frame: 1 month
Minimum value: 1, Maximum value: 6, Higher scores reflect higher satisfaction with life (i.e., better outcome)
1 month
Religious Commitment Inventory
Time Frame: 1 month
Minimum value: 1, Maximum value: 5, Higher scores reflect higher religious commitment (i.e., better outcome)
1 month
Multiethnic Identity Measure
Time Frame: 1 month
Minimum value: 1, Maximum value: 5, Higher scores reflect higher ethnic identity (i.e., better outcome)
1 month
Perceived Stress Scale
Time Frame: 1 month
Minimum value: 0, Maximum value: 5, Higher scores reflect higher stress (i.e., worse outcome)
1 month
Hospital Anxiety and Depression Scale
Time Frame: 1 month
Minimum value: 0, Maximum value: 3, Higher scores reflect higher anxiety/depression (i.e., worse outcome)
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Biola University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Todd Hall, PhD, Biola University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 24, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
June 19, 2023

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 19, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
November 8, 2022

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 15, 2022

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
November 25, 2022

Study Record Updates

Last Update Posted (Estimated)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
September 30, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 17, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • F22-013

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings